首页> 美国卫生研究院文献>Frontiers in Public Health >Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements
【2h】

Biosafety and Biosecurity in European Containment Level 3 Laboratories: Focus on French Recent Progress and Essential Requirements

机译:欧洲遏制三级实验室的生物安全性和生物安全性:关注法国的最新进展和基本要求

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Even if European Union (EU) Member States are obliged to implement EU Directives 2000/54/EC on the protection of workers from risks related to exposure to biological agents at work, national biosafety regulations and practices varied from country to country. In fact, EU legislation on biological agents and genetically modified microorganisms is often not specific enough to ensure harmonization leading to difficulties in implementation for most laboratories. In the same way, biosecurity is a relatively new concept and a few EU Member States are known to have introduced national laboratory biosecurity legislation. In France, recent regulations have reinforced biosafety/biosecurity in containment level 3 (CL-3) laboratories but they concern a specific list of pathogens with no correlation in other European Members States. The objective of this review was to summarize European biosafety/biosecurity measures concerning CL-3 facilities focusing on French specificities. Essential requirements needed to preserve efficient biosafety measures when manipulating risk group 3 biological agents are highlighted. In addition, International, European and French standards related to containment laboratory planning, operation or biosafety equipment are described to clarify optimal biosafety and biosecurity requirements.
机译:即使欧盟(EU)成员国有义务执行关于保护工人免受与工作中接触生物制剂有关的风险的欧盟指令2000/54 / EC,各国的国家生物安全法规和惯例也会有所不同。实际上,欧盟关于生物制剂和转基因微生物的立法通常不够具体,无法确保协调统一,导致大多数实验室难以实施。同样,生物安全性是一个相对较新的概念,众所周知,一些欧盟成员国已经引入了国家实验室生物安全性法规。在法国,最新法规加强了3级收容所(CL-3)实验室的生物安全性/生物安全性,但它们涉及特定的病原体列表,而在其他欧洲成员国中却没有相关性。这次审查的目的是总结有关CL-3设施的欧洲生物安全/生物安全措施,重点是法国的特殊性。强调了在操纵第3类风险生物制剂时保持有效的生物安全措施所需的基本要求。此外,还介绍了与遏制实验室计划,操作或生物安全设备有关的国际,欧洲和法国标准,以阐明最佳的生物安全和生物安全要求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号